ReviewFrontiers in oncology2020
The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer.
Hui Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it
ReviewFrontiers in oncology2020
Hui Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.